Cooper EBIT 2012-2026 | COO
Cooper annual and quarterly EBIT history from 2012 to 2026. EBIT can be defined as earnings before interest and taxes.
- Cooper EBIT for the quarter ending April 30, 2026 was $-31M, a 116.77% decline year-over-year.
- Cooper EBIT for the twelve months ending April 30, 2026 was $0.498B, a 34.29% decline year-over-year.
- Cooper 2025 annual EBIT was $0.683B, a 3.23% decline from 2024.
- Cooper 2024 annual EBIT was $0.706B, a 32.38% increase from 2023.
- Cooper 2023 annual EBIT was $0.533B, a 5.02% increase from 2022.
|
Cooper Annual EBIT (Millions of US $) |
|
|---|---|
| 2025 | $683 |
| 2024 | $706 |
| 2023 | $533 |
| 2022 | $508 |
| 2021 | $506 |
| 2020 | $312 |
| 2019 | $547 |
| 2018 | $403 |
| 2017 | $429 |
| 2016 | $324 |
| 2015 | $237 |
| 2014 | $306 |
| 2013 | $306 |
| 2012 | $283 |
| 2011 | $228 |
|
Cooper Quarterly EBIT (Millions of US $) |
|
|---|---|
| 2026-04-30 | $-31 |
| 2026-01-31 | $213 |
| 2025-10-31 | $140 |
| 2025-07-31 | $176 |
| 2025-04-30 | $185 |
| 2025-01-31 | $182 |
| 2024-10-31 | $198 |
| 2024-07-31 | $193 |
| 2024-04-30 | $162 |
| 2024-01-31 | $153 |
| 2023-10-31 | $136 |
| 2023-07-31 | $152 |
| 2023-04-30 | $96 |
| 2023-01-31 | $150 |
| 2022-10-31 | $104 |
| 2022-07-31 | $141 |
| 2022-04-30 | $133 |
| 2022-01-31 | $131 |
| 2021-10-31 | $129 |
| 2021-07-31 | $101 |
| 2021-04-30 | $143 |
| 2021-01-31 | $133 |
| 2020-10-31 | $100 |
| 2020-07-31 | $72 |
| 2020-04-30 | $29 |
| 2020-01-31 | $111 |
| 2019-10-31 | $147 |
| 2019-07-31 | $142 |
| 2019-04-30 | $147 |
| 2019-01-31 | $111 |
| 2018-10-31 | $123 |
| 2018-07-31 | $116 |
| 2018-04-30 | $75 |
| 2018-01-31 | $90 |
| 2017-10-31 | $109 |
| 2017-07-31 | $113 |
| 2017-04-30 | $117 |
| 2017-01-31 | $91 |
| 2016-10-31 | $74 |
| 2016-07-31 | $103 |
| 2016-04-30 | $90 |
| 2016-01-31 | $57 |
| 2015-10-31 | $42 |
| 2015-07-31 | $50 |
| 2015-04-30 | $71 |
| 2015-01-31 | $73 |
| 2014-10-31 | $39 |
| 2014-07-31 | $97 |
| 2014-04-30 | $89 |
| 2014-01-31 | $82 |
| 2013-10-31 | $62 |
| 2013-07-31 | $94 |
| 2013-04-30 | $81 |
| 2013-01-31 | $69 |
| 2012-10-31 | $79 |
| 2012-07-31 | $77 |
| 2012-04-30 | $65 |
| 2012-01-31 | $62 |
| 2011-10-31 | $67 |
| 2011-07-31 | $52 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $13.894B | $4.092B |
| The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |